Equipping you with the tools you need to provide the best
health care for your patients.
Medriva is a world leading manufacturer and provider of safety injection needles and syringes, continually pioneering the development of high-quality, easy-to-use injection devices designed to protect healthcare workers from needle-stick injuries and exposure to blood borne pathogens. We offer one of the most complete lines of advanced safety-engineered products in the industry.
Medriva rapidly scaled its annual production output to two billion syringes that globally services customers such as: PAHO, UNICEF, Health Canada, Ministero della Difesa, and Sinovac.
Internationally approved test kits
COVID-19 has seen the world impacted in almost every corner of life, from global economies, to the way we interact with our loved ones. With such emphasis put on how important the vaccine is to a sustainable exit from the pandemic, the world seemed to forget about the obvious problem they were faced with huge impacts on our supply chain and manufacturing systems. There were simply not enough raw materials for syringes to deliver the huge scales of vaccine doses imposed by government regulations.
Two billion COVID-19 vaccinations in less than 2 years
Under a year on from this announcement, on February 2022, Medriva has proudly aided 1 billion COVID-19 vaccinations worldwide. We aren’t stopping there, as we stand committed for over a billion more in 2022.
A worldwide shortage of COVID-19 vaccination syringes
Since the World Health Organization declared the COVID-19 outbreak a pandemic back in March 2020, the virus has claimed more than 10 million lives globally. In June 2021, widespread panic and supply chain imbalances resulted in the WHO announcing, the worldwide shortage of COVID-19 vaccination syringes. This created crippling headaches for governments and health organisations globally, as they could not meet critical vaccination targets to relieve pressure off health care systems around the world.
Two billion vaccinations
A worldwide shortage
We are proud to be
Ever since the start of the pandemic, Medriva has been working closely with top epidemiologists, manufacturers and leading health organisations to successfully deliver our products to cover over at least 15% of the world’s population. We stand committed into our fight to help vaccinate the world from this pandemic and will always ensure every country has access to vaccine supplies.
five syringes used in COVID-19
vaccinations this year will be a
Medriva 1ml with Needle 25Gx1” needle (sterile)
Medriva 0.5ml Auto-Disable Syringe with 23G x 1” Needle
Medriva 0.3ml Auto-Disable Syringe with 23G x 1” Needle
Medriva 0.5ml Auto-Disable Syringe with 24G x 1” Needle
Medriva 0.5ml Auto-Disable Syringe with 23G x 1” Needle in blister pack
Medriva 1ml STD luer lock PFS, Sterile
Medriva 1ml STD w/ Staked Needle PFS, Sterile
How to buy
Reach out to our team for ordering information.
Medriva specializes in supporting medication delivery and offers a line of both standard and safety needles and syringes. Our Medriva needles and syringes are engineered to keep patients and clinicians safe at every step, from vaccine and medication delivery to disposal.
By making medical devices disposable, the number of incidences of patients being infected has been greatly reduced. Even then, the complete elimination of needle-stick injuries and miss-dosage of drugs, and the absolute guarantee of greater safety for medical personnel and patients have become major issues. The consideration of environmental problems caused by medical waste is also something that must be addressed. At Medriva, we are in the forefront of the prevention of needle-stick and miss-connection incidents and are bringing out more and more unique products that can help to maintain a truly safe system. We have taken the initiative in the development and utilization of new materials and devices that are friendly both to people and the environment.
In 1999, WHO and UNICEF began to address the spread of blood-borne diseases through reuse of needles and syringes by recommending that auto-disable syringes be used for all immunizations. Since that time, auto-disable syringes have become widely accepted by the international healthcare community. AD syringes are recommended for immunization programmes because they are designed to prevent re-use by locking automatically after a single use. They are the best way of ensuring that people receive their shots safely, without a risk of contracting an infection due to contaminated needles. The AD syringes bought for this immense operation are similar to those routinely procured and delivered by UNICEF for the vaccination of children worldwide.
The pre-fillable syringe market has grown significantly in the past years. Pharmaceutical companies are developing an increasing number of drug products in injectable formats, since this packaging type offers
exceptional benefits: decreased total cost of ownership, improved drug-container compatibility, and increased patient safety. Medriva’s PFS provides pharmaceutical manufacturers, health-care providers, and patients with several benefits that include: patient compliance, reduction of dosing errors, minimized risk of contamination, and the promotion of safe injections.
Medriva is built on protection
there using innovation, product development, and
the most advanced R&D team.